Search results
Results from the WOW.Com Content Network
Donepezil, sold under the brand name Aricept among others, is a medication used to treat dementia of the Alzheimer's type. [3] [4] [8] It appears to result in a small benefit in mental function and ability to function. [9] Use, however, has not been shown to change the progression of the disease. [10] Treatment should be stopped if no benefit ...
The cybersecurity company's stock has risen by nearly 360%, which prompted management to conduct a 2-for-1 stock split on Dec. 16. While a stock split is mostly cosmetic, and doesn't change ...
Dementia is a devastating condition that impacts up to 10 percent of older adults. And while there's no cure, getting diagnosed early can help patients get on a treatment plan and families prepare ...
On Tuesday, CervoMed Inc. (NASDAQ:CRVO) stock is trading lower after the company revealed topline data from the RewinD-LB Phase 2b clinical trial evaluating neflamapimod for dementia with Lewy ...
[17] [18] One guideline recommends memantine or an AChE inhibitor be considered in people in the early-to-mid stage of dementia. [ 19 ] Memantine has been associated with a modest improvement; [ 20 ] with small positive effects on cognition , mood, behavior, and the ability to perform daily activities in moderate-to-severe Alzheimer's disease.
Because hypnosis can recreate the false beliefs (accounting for factor 1 of the two-factor theory of delusional belief above) and disrupt the ability to reject a belief on implausibility (accounting for factor 2) with no lasting consequences, it is a good model to study monothematic delusions, particularly mirrored-self misidentification.
Applied Materials has already split its stock nine times since its initial public offering (IPO) in 1972. If you had bought 100 of its IPO shares at $10 for $1,000, you would now be holding 28,800 ...
Posterior cortical atrophy (PCA), also called Benson's syndrome, is a rare form of dementia which is considered a visual variant or an atypical variant of Alzheimer's disease (AD). [ 1 ] [ 2 ] [ 3 ] The disease causes atrophy of the posterior part of the cerebral cortex , resulting in the progressive disruption of complex visual processing . [ 4 ]